396 related articles for article (PubMed ID: 26643568)
1. Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.
Narayanan S; Srinivas S; Feldman D
Nat Rev Urol; 2016 Jan; 13(1):47-60. PubMed ID: 26643568
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
3. The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.
Hu J; Chen Q
Int Urol Nephrol; 2017 Mar; 49(3):369-380. PubMed ID: 27987128
[TBL] [Abstract][Full Text] [Related]
4. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
Martin SK; Kyprianou N
Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
[TBL] [Abstract][Full Text] [Related]
5. Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer.
Bastos DA; Dzik C; Rathkopf D; Scher HI
Oncology (Williston Park); 2014 Aug; 28(8):693-9. PubMed ID: 25140626
[TBL] [Abstract][Full Text] [Related]
6. [Qualitative and quantitative hormonal regulation in castration-resistant prostate cancer].
Murez T; Basset V; Audenet F; Lebret T; Branchereau J
Prog Urol; 2013 Oct; 23 Suppl 1():S1-8. PubMed ID: 24314734
[TBL] [Abstract][Full Text] [Related]
7. Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further.
Fujimoto N
J UOEH; 2016 Jun; 38(2):129-38. PubMed ID: 27302726
[TBL] [Abstract][Full Text] [Related]
8. [ASC-J9 for castration-resistant prostate cancer].
Yamashita S; Arai Y
Nihon Rinsho; 2014 Dec; 72(12):2126-9. PubMed ID: 25518345
[TBL] [Abstract][Full Text] [Related]
9. Quo vadis: advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies.
Kim W; Ryan CJ
Cancer; 2015 Feb; 121(3):361-71. PubMed ID: 25236176
[TBL] [Abstract][Full Text] [Related]
10. Triple-arm androgen blockade for advanced prostate cancer: a review.
Desai MH; Parsi M; Potdar RR
Med Oncol; 2021 May; 38(7):75. PubMed ID: 34032938
[TBL] [Abstract][Full Text] [Related]
11. The role of adrenal derived androgens in castration resistant prostate cancer.
Barnard M; Mostaghel EA; Auchus RJ; Storbeck KH
J Steroid Biochem Mol Biol; 2020 Mar; 197():105506. PubMed ID: 31672619
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of hydrocortisone esters targeting androgen and glucocorticoid receptors in prostate cancer in vitro.
Peřina M; Kiss A; Mernyák E; Mada L; Schneider G; Jorda R
J Steroid Biochem Mol Biol; 2023 May; 229():106269. PubMed ID: 36773737
[TBL] [Abstract][Full Text] [Related]
13. Reconsideration of progression to CRPC during androgen deprivation therapy.
Mizokami A; Namiki M
J Steroid Biochem Mol Biol; 2015 Jan; 145():164-71. PubMed ID: 24717975
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.
Imamura Y; Sadar MD
Int J Urol; 2016 Aug; 23(8):654-65. PubMed ID: 27302572
[TBL] [Abstract][Full Text] [Related]
15. [Androgen biosynthesis in castration-resistant prostate cancer: Advances in studies].
Chen B; Cao DH; Guo JB; Liu LR; Wei Q
Zhonghua Nan Ke Xue; 2019 Mar; 25(3):265-271. PubMed ID: 32216246
[TBL] [Abstract][Full Text] [Related]
16. The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.
Puhr M; Hoefer J; Eigentler A; Ploner C; Handle F; Schaefer G; Kroon J; Leo A; Heidegger I; Eder I; Culig Z; Van der Pluijm G; Klocker H
Clin Cancer Res; 2018 Feb; 24(4):927-938. PubMed ID: 29158269
[No Abstract] [Full Text] [Related]
17. [Mechanisms of drug resistance in endocrinotherapy for castration-resistant prostate cancer].
Bo B; Guo JB; Liu LR; Wei Q
Zhonghua Nan Ke Xue; 2021 Feb; 27(2):167-171. PubMed ID: 34914335
[TBL] [Abstract][Full Text] [Related]
18. [Advances in the studies of androgen metabolism and de novo androgen synthesis in castration resistant prostate cancer].
Wang B; Wu KJ; He DL
Zhonghua Nan Ke Xue; 2013 Aug; 19(8):736-41. PubMed ID: 24010211
[TBL] [Abstract][Full Text] [Related]
19. Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor Signaling.
Zaslavsky AB; Gloeckner-Kalousek A; Adams M; Putluri N; Venghatakrishnan H; Li H; Morgan TM; Feng FY; Tewari M; Sreekumar A; Palapattu GS
Neoplasia; 2015 Jun; 17(6):490-6. PubMed ID: 26152357
[TBL] [Abstract][Full Text] [Related]
20. Androgen Deprivation Therapy and Secondary Hormone Therapy in the Management of Hormone-sensitive and Castration-resistant Prostate Cancer.
Saad F; Fizazi K
Urology; 2015 Nov; 86(5):852-61. PubMed ID: 26282624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]